50-49-7|5H-Dibenz[b,f]azepine-5-propanamine,10,11-dihydro-N,N-dimethyl-Products Supply

5H-Dibenz[b,f]azepine-5-propanamine,10,11-dihydro-N,N-dimethyl- cas no:50-49-7

Synonyms: 5H-Dibenz[b,f]azepine,5-[3-(dimethylamino)propyl]-10,11-dihydro- (7CI,8CI); 1-(3-Dimethylaminopropyl)-4,5-dihydro-2,3,6,7-dibenzazepine;5,6-Dihydro-N-[3-(dimethylamino)propyl]-11H-dibenz[b,e]azepine;5-(3-Dimethylaminopropyl)-10,11-dihydro-5H-dibenz[b,f]azepine; Antideprin;Berkomine; Cristalia; Imipramine; Melipramine; N-(3-Dimethylaminopropyl)-o-iminodibenzyl;N-(g-Dimethylaminopropyl)iminodibenzyl;NSC 169866; Org 2463; Prazepine; Sermonil

Identification

Name5H-Dibenz[b,f]azepine-5-propanamine,10,11-dihydro-N,N-dimethyl-
CAS50-49-7
Synonyms5H-Dibenz[b,f]azepine,5-[3-(dimethylamino)propyl]-10,11-dihydro- (7CI,8CI); 1-(3-Dimethylaminopropyl)-4,5-dihydro-2,3,6,7-dibenzazepine;5,6-Dihydro-N-[3-(dimethylamino)propyl]-11H-dibenz[b,e]azepine;5-(3-Dimethylaminopropyl)-10,11-dihydro-5H-dibenz[b,f]azepine; Antideprin;Berkomine; Cristalia; Imipramine; Melipramine; N-(3-Dimethylaminopropyl)-o-iminodibenzyl;N-(g-Dimethylaminopropyl)iminodibenzyl;NSC 169866; Org 2463; Prazepine; Sermonil
EINECS(EC#)200-042-1
Molecular FormulaC19H24 N2
Molecular Weight280.45

Chemical Properties

refractive index1.574

Safety Data

Safety

A human poison by ingestion. An experimental poison by ingestion, subcutaneous, intravenous, and intraperitoneal routes. Human systemic effects by ingestion: somnolence, hallucinations, distorted perceptions, changes in motor activity, ataxia (loss of muscle coordination), coma, nausea and vomiting, irritative dermatitis. An experimental teratogen by ingestion. Other experimental reproductive effects. Mutation data reported. When heated to decomposition it emits toxic fumes of NO_x.

Toxicity

Organism	Test Type	Route	Reported Dose (Normalized Dose)	Effect	Source
cat	LDLo	intravenous	20mg/kg (20mg/kg)		Bollettino Chimico Farmaceutico. Vol. 112, Pg. 601, 1973.
cat	LDLo	oral	100mg/kg (100mg/kg)		Zentralblatt fuer Pharmazie, Pharmakotherapie und Laboratoriums-diagnostik. Vol. 114, Pg. 787, 1975.
child	LD50	oral	40mg/kg (40mg/kg)	BEHAVIORAL: "HALLUCINATIONS, DISTORTED PERCEPTIONS" BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY) BEHAVIORAL: COMA	Handbook of Experimental Pharmacology. Vol. 55, Pg. 527, 1980.
child	LDLo	oral	35mg/kg (35mg/kg)	BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: DYSPNEA CARDIAC: OTHER CHANGES	Schweizerische Medizinische Wochenschrift. Vol. 99, Pg. 1157, 1969.
child	TDLo	oral	30mg/kg (30mg/kg)	BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY) BEHAVIORAL: ATAXIA	American Journal of Diseases of Children. Vol. 130, Pg. 507, 1976.
dog	LDLo	intravenous	45mg/kg (45mg/kg)	PERIPHERAL NERVE AND SENSATION: FLACCID PARALYSIS WITHOUT ANESTHESIA (USUALLY NEUROMUSCULAR BLOCKAGE) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION	Bollettino Chimico Farmaceutico. Vol. 112, Pg. 601, 1973.
dog	LDLo	oral	100mg/kg (100mg/kg)		"Psychotropic Drugs and Related Compounds," 2nd ed., Usdin, E., and D.H. Efron, Washington, DC, 1972Vol. -, Pg. 78, 1972.
human	LD50	oral	40mg/kg (40mg/kg)		Proceedings of the European Society for the Study of Drug Toxicity. Vol. 6, Pg. 171, 1965.
human	LDLo	oral	450mg/kg (450mg/kg)	SKIN AND APPENDAGES (SKIN): "DERMATITIS, IRRITATIVE: AFTER SYSTEMIC EXPOSURE"	British Medical Journal. Vol. 1, Pg. 722, 1979.
mammal (species unspecified)	LD50	oral	350mg/kg (350mg/kg)	BEHAVIORAL: ANTICONVULSANT	Journal of Medicinal Chemistry. Vol. 8, Pg. 836, 1965.
mammal (species unspecified)	LD50	unreported	455mg/kg (455mg/kg)		Khimiko-Farmatsevticheskii Zhurnal. Chemical Pharmaceutical Journal. For English translation, see PCJOAU. Vol. 24(7), Pg. 27, 1990.
man	LD50	oral	30mg/kg (30mg/kg)	BEHAVIORAL: "HALLUCINATIONS, DISTORTED PERCEPTIONS" BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY) BEHAVIORAL: COMA	Handbook of Experimental Pharmacology. Vol. 55, Pg. 527, 1980.
man	LDLo	oral	71mg/kg (71mg/kg)	BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD CARDIAC: CHANGE IN RATE ENDOCRINE: CHANGE IN LH	Journal of Toxicology, Clinical Toxicology. Vol. 19, Pg. 239, 1982.
man	TDLo	oral	5357ug/kg/5D- (5.357mg/kg)	BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: CHANGE IN REM SLEEP (HUMAN)	Human Psychopharmacology. Vol. 11, Pg. 211, 1996.
man	TDLo	oral	8mg/kg/3D-I (8mg/kg)	BEHAVIORAL: EXCITEMENT	Lancet. Vol. 2, Pg. 568, 1959.
man	TDLo	oral	71428ug/kg/10 (71.428mg/kg)	BEHAVIORAL: REGIDITY SKIN AND APPENDAGES (SKIN): SWEATING: OTHER	Intensive Care Medicine. Vol. 23, Pg. 480, 1997.
mouse	LD50	intraperitoneal	51600ug/kg (51.6mg/kg)		British Patent Document. Vol. #1460700,
mouse	LD50	intravenous	21mg/kg (21mg/kg)	AUTONOMIC NERVOUS SYSTEM: PARASYMPATHOLYTIC BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY) BEHAVIORAL: WAKEFULNESS	Archives Internationales de Pharmacodynamie et de Therapie. Vol. 245, Pg. 283, 1980.
mouse	LD50	oral	188mg/kg (188mg/kg)	SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY)	Pharmaceutical Chemistry Journal Vol. 14, Pg. 773, 1980.
mouse	LD50	subcutaneous	195ug/kg (0.195mg/kg)	BEHAVIORAL: WAKEFULNESS	Pharmaceutical Chemistry Journal Vol. 15, Pg. 412, 1981.
mouse	LD50	unreported	107mg/kg (107mg/kg)	AUTONOMIC NERVOUS SYSTEM: "SMOOTH MUSCLE RELAXANT (MECHANISM UNDEFINED, SPASMOLYTIC)"	Journal of Medicinal Chemistry. Vol. 10, Pg. 418, 1967.
rabbit	LD50	intravenous	18mg/kg (18mg/kg)		Archives Internationales de Pharmacodynamie et de Therapie. Vol. 120, Pg. 450, 1959.
rabbit	LD50	oral	385mg/kg (385mg/kg)		Arzneimittel-Forschung. Drug Research. Vol. 19, Pg. 1617, 1969.
rat	LD50	intraperitoneal	79mg/kg (79mg/kg)		Archives Internationales de Pharmacodynamie et de Therapie. Vol. 148, Pg. 560, 1964.
rat	LD50	intravenous	9300ug/kg (9.3mg/kg)		United States Patent Document. Vol. #4141993,
rat	LD50	oral	250mg/kg (250mg/kg)	SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY)	Pharmaceutical Chemistry Journal Vol. 14, Pg. 773, 1980.
rat	LD50	subcutaneous	250mg/kg (250mg/kg)		Archives Internationales de Pharmacodynamie et de Therapie. Vol. 148, Pg. 560, 1964.
women	LDLo	oral	2mg/kg/1D (2mg/kg)	LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES	Journal of Pharmacy and Pharmacology. Vol. 16, Pg. 265, 1964.
women	TDLo	oral	3mg/kg/32H-I (3mg/kg)	SKIN AND APPENDAGES (SKIN): PHOTOSENSITIVITY: AFTER SYSTEMIC EXPOSURE	JAMA, Journal of the American Medical Association. Vol. 254, Pg. 357, 1985.
women	TDLo	oral	150mg/kg (150mg/kg)	BEHAVIORAL: COMA CARDIAC: OTHER CHANGES VASCULAR: BP LOWERING NOT CHARACTERIZED IN AUTONOMIC SECTION	Journal of Toxicology, Clinical Toxicology. Vol. 33, Pg. 51, 1995.

supplier list

Hangzhou Dayangchem Co., Ltd.: Tel:86-571-88938639; Address: 9/F Unit 2 ChangdiTorch Building, 259 #WenSan Road

Capot Chemical Co., Ltd.: Tel:86-571-85586718; Address: Joinhands Science Park, No.4028,Nanhuan Road,

Beijing HuameiHuli Biochem Ltd: Tel:010-86181995; Address: Beijing TongZhou District

Shreeji Pharma International: Tel:+91-265-3019110; Address: FF/10, Narsinghdham Complex, Sangam Chararasta, Harni Road, Vadodara, Gujarat 390018,

Varda Biotech Pvt. Ltd.: Tel:+91-(22)-6693 5686; Address: #110 & 111 Kartik Complex, New Link Road, Andheri (W), Mumbai, Maharashtra 400 053,

Wuhan Dahua Weiye Pharmaceutical Co.,Ltd: Tel:86-27-59335372; Address: daijiashan 45,jiangan economic departmen zone,wuhan,hubei,China

Zhejiang Haiqiang Chemical Co.,Ltd.: Tel:86-571-86960370; Address: 5/F, Around Town North Road,No. 10, Hangzhou, Zhejiang,China

Andexin industrial Co.,Limited: Tel:86-411-39074598; Address: No.98,Shengli road,,Jinzhou district,

Nanjing Chemlin Chemical Co., Ltd.: Tel:86-25-83697070; Address: Rm.902 Longyin Plaza, No. 217 Zhongshan Rd.(N) Nanjing 210009,China

Cambridge Isotope: Tel:+1-978-749-8000; Address: Cambridge Isotope Laboratories 50 Frontage Road Andover, MA 01810-5413

Tianjin Harmony Technology Development Co., Ltd.: Tel:; Address: Room 601 of BokeBuilding, 100 Fukang Road, Tianjin, China

Swiss Pharma Pvt. Ltd.: Tel:+91-(79)-26574432, 26577097; Address: 8B, Medicare Building, Ellisbridge, Ahmedabad, Gujarat 380 015,

Shon Products: Tel:; Address: Plot No. 17-A, Sattur Industrial Estate, Dharwad, Andhra Pradesh 580002,

Labortorio Dosa S.A: Tel:54 11 4551-4965 / 4554; Address: Girardot 1369 (C1427AKC) City of Buenos Aires,

Aliapharm: Tel:+49 69 971412-0; Address: AliaPharm GmbH Frankfurt Niedenau 49 60325 Frankfurt / Main

5H-Dibenz[b,f]azepine-5-propanamine,10,11-dihydro-N,N-dimethyl- cas no:50-49-7

Directory

supplier list